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Abstract
Background: For the conclusive diagnosis of Cushing's Syndrome, a stimulating ACTH test or a
low suppressive Dexamethasone test is used. Reports in other species than the dog indicate that
plasma cortisol concentration after ACTH administration is affected by gender. We investigated
the effect of gender on the cortisol response to ACTH and Dexamethasone tests in dogs.
Methods: Seven healthy adult Cocker Spaniels (4 females and 3 males) were assigned to a two by
two factorial design: 4 dogs (2 females and 2 males) received IV Dexamethasone 0.01 mg/kg, while
the other 3 dogs received an IV saline solution (control group). Two weeks later the treatments
were reversed. After one month, ACTH was given IV (250 μg/animal) to 4 dogs (2 female and 2
males) while the rest was treated with saline solution (control group). Cortisol concentrations
were determined by a direct solid-phase radioimmunoassay and cholesterol and triglycerides by
commercial kits.
Results and Discussion: No effect of treatment was observed in metabolite concentrations, but
females presented higher cholesterol concentrations. ACTH-treated dogs showed an increase in
cortisol levels in the first hour after sampling until 3 hours post injection. Cortisol concentrations
in Dexamethasone-treated dogs decreased one hour post injection and remained low for 3 hours,
thereafter cortisol concentrations increased. The increase in cortisol levels from one to two hours
post ACTH injection was significantly higher in females than males. In Dexamethasone-treated
males cortisol levels decreased one hour post injection up to 3 hours; in females the decrease was
more pronounced and prolonged, up to 5 hours post injection.
Conclusion:  We have demonstrated that cortisol response to ACTH and Dexamethasone
treatment in dogs differs according to sex.
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Background
Cushing's Syndrome (CS) is a disorder associated with
excessive glucocorticoid production. The CS is one of the
most common endocrine pathologies in dogs [1,2]. The
excess of cortisol affects different tissues and metabolic
pathways, such as the carbohydrate and lipid pathways [3-
6]. As a result dogs show glucose intolerance, hyperglyc-
emia and hyperlipemia accompanied with an increase in
triglycerides and total cholesterol, [4,7,8] causing signs as
polyuria, polydipsia, polyphagia and abdominal enlarge-
ment. All characteristics of Cushing's Syndrome [9,10].
Even though it is possible to diagnose CS by clinical signs,
laboratory tests and radiology/ecography exams, the syn-
drome should be confirmed by hormone determination
[10]. Determination of basal cortisol is of no meaning,
levels are very variable and affected by the stress of sam-
pling. Thus, for the conclusive diagnosis a stimulating
ACTH test or a low suppressive Dexamethasone test is
used [11]. The suggested hours for sampling after ACTH
administration are 30 to 60 min post-injection and for the
low dose Dexamethasone test 3 to 4 and 8 hours after the
injection [10].
Many laboratories have established reliable reference val-
ues for cortisol concentrations in blood of clinically nor-
mal animals. However, non pathologic factors that affect
adrenocortical secretion may lead to misinterpretation of
test results. For other species (humans, ruminants) a gen-
der effect on cortisol concentrations exists [12], but in
dogs no sex effect has been found [13]. In sheep, plasma
cortisol concentrations after ACTH administration were
higher in females than in males [14]. Cortisol affects car-
bohydrate and lipid metabolism, and even if it is known
that ACTH/Dexamethasone administration affects corti-
sol levels, we found no reports on their effects on choles-
terol and triglycerides levels in dogs.
The aim of this study was to determine the effect of ACTH
and the low-dose Dexamethasone test on cortisol concen-
trations determined hourly in healthy male and female
dogs. We also investigated the effects of these tests on cho-
lesterol and triglycerides levels.
Materials and methods
Animals and blood sampling
Seven healthy adult Cocker Spaniels, 6 to 9 years of age (3
males and 4 females) were used. The mean (± SEM)
weight of these animals was 9 ± 0.7 kg. Animals were fed
with a commercial diet (Excelent, Purina, Nestlé, Buenos
Aires, Argentina) at 20:00 hours. Animal experimentation
was performed in compliance with regulations set by the
Veterinary Faculty, University of Uruguay, Uruguay.
Animal management and blood sampling was the same in
both experimental designs. Animals were catheterized in
the cephalic vein at 6:00 and blood samples were taken
every hour from 7:00 until 17:00 hours in heparinized
vials. Infusions of ACTH, Dexamethasone or saline solu-
tions were given at 9:00 (e.g. two hours after the initiation
of the blood sampling). Blood samples were centrifuged
at 3000 rpm for 15 min and plasma was stored at -20°C
until assayed.
Experimental Design 1: Low-dose Dexamethasone test
A cross-over design was performed: Dexamethasone 0.01
mg/kg (Dispert S.A., Montevideo, Uruguay) was given IV
to four dogs (2 females and 2 males), while the other 3
dogs received IV saline solution. Two weeks later, the Dex-
amethasone-treated animals received the IV saline solu-
tion, while the previous control dogs were treated with the
same Dexamethasone dose.
Experimental Design 2: ACTH test
ACTH was given IV at a dose of 250 μg/animal (Novartis
Farmaceutica LTD, England) to 4 dogs (2 females and 2
males) while the rest received saline solution (control
group).
Hormone determination
Plasma samples were assayed in the Laboratory of Nuclear
Techniques, Veterinary Faculty, Montevideo, Uruguay.
Cortisol concentrations were determined by a direct solid-
phase radioimmunoassay using DPC kits (Diagnostic
Products Corporation, Los Angeles, CA, USA). The analyt-
ical detection limit of the assay was 9.6 nmol/L. The intra-
assay coefficients of variation for low (27.6 nmol/L) and
medium controls (138.0 nmol/L) were 3.4% and 5.3%,
respectively. The inter-assay coefficients of variation for
the same controls were 8.7% and 7.6%, respectively.
Metabolite determination
The methods and commercial kits used were: Cholesterol
by enzymatic AA method (Wiener Lab 1220114, Rosario-
Argentina) and Triglycerides by GPO/PAP AA Wiener Lab
1780112, Rosario-Argentina). The standatrol was used as
an internal control (Wiener Lab 1937553, Rosario-Argen-
tina). The intra-assay coefficient of variation was below
10%.
Statistical Analyses
Cortisol, cholesterol and triglycerides concentrations were
analyzed by the mixed procedure (PROC MIXED de SAS®,
Statistical Analysis System, SAS Institute Inc., Cary, NC,
USA 2000). The statistical model included the effects of
treatment, gender and hour of sampling and their interac-
tions. Data are presented in graphs as least square means
± pooled standard error. Significance was consideredActa Veterinaria Scandinavica 2009, 51:33 http://www.actavetscand.com/content/51/1/33
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when P ≤ 0.05, and values between P > 0.05 and P < 0.1
were considered a trend.
Results
Test effect
Sampling time, treatment and their interaction had a sig-
nificant effect on cortisol concentrations (P < 0.0001 for
all effects). Cortisol concentrations in Dexamethasone
treated dogs decreased one hour post injection and
remained low for 3 hours, thereafter cortisol concentra-
tions increased. ACTH-test dogs showed an increase in
cortisol levels in the first hour after sampling until 3 hours
post injection. No differences from basal levels were
found 4 hours post injection (Figure 1). No effect of time
of sampling on cortisol levels were observed in control
dogs (Figure 1). No effect of sampling on cholesterol lev-
els were observed, but triglyceride concentrations
decreased at the end of the sampling period (Figure 2).
Gender effect
A significant interaction between sex*treatment (P <
0.0001) and sex*treatment*time of sampling (P =
0.0095) on cortisol concentrations were found. In the
Dexamethasone-treated males cortisol levels decreased
one hour post injection and returned to pre-treatment lev-
els 3 hours later. In the females the decrease was more
pronounced and prolonged, returning to pre-treatment
levels 6 hours post injection (Figure 3A). This resulted in
that cortisol levels were lower in females 4 and 5 hours
after Dexamethasone injection. The increase in cortisol
levels from one to two hours post ACTH injection was sig-
nificantly higher in females than males (P < 0.001) (Fig-
ure 3B). Control dogs did not show differences among
gender (Figure 3C).
There was an effect of gender on cholesterol and triglycer-
ides concentrations, as females had higher cholesterol lev-
els (6.2 ± 0.26 vs 5.2 ± 0.26 mmol/L, P < 0.0001) and
triglycerides concentrations (0.91 ± 0.08 vs 0.80 ± 0.07
mmol/L respectively). Since there was no effect of treat-
ment or sampling time on metabolite concentrations,
data was pooled according to gender (Figure 2).
Discussion
A circadian rhythm for cortisol secretion has been
reported for humans, monkeys and rats, but this is contra-
dictory in dogs [15-17]. In the present study, cortisol con-
centrations were measured hourly for 10 hours and no
variations were observed. No changes were found in cho-
lesterol concentrations, but triglycerides levels decreased
at the end of the experimental period probably due to the
prolonged time from the last meal (17 hours after intake).
No effect of treatment was observed in cortisol concentra-
tions. Dexamethasone-treated dogs presented a decrease
Cortisol concentrations after ACTH, Dexamethasone and  Saline solution treatments in healthy Cocker Spaniel dogs Figure 1
Cortisol concentrations after ACTH, Dexametha-
sone and Saline solution treatments in healthy 
Cocker Spaniel dogs.
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in the first hour post injection that lasted until 3 hours
post injection. Feldman and Nelson [18] found a similar
suppression of cortisol secretion after Dexamethasone
treatment in dogs sampled hourly, although the levels
remained low up to 8 hours post injection. This difference
cannot be attributed to the dose, but it could be due to the
adjuvant and/or management of the animals (e.g., breed,
hours of fasting). Cortisol response to stimulation with
ACTH and inhibition with Dexamethasone was similar to
other reports considering not only the maximum cortisol
concentrations after treatment, but also the duration of
the response [18-20]. In the present study, ACTH-treated
dogs maintained high cortisol levels up to 3 hours post
injection; while Hansen et al (1994)[19] -sampling every
30 min- found a significant increase, similar to ours, in
the first 30 min post-injection and a maximum concentra-
tion 1.5 hours after injection. Their sampling ended at 2.5
hours and cortisol concentrations were  although lower
than 1.5 hour post injection- still different from baseline.
Although our study used a small number of animals, it
should be noted that the frequent sampling and cortisol
concentrations could not be attributed to the stress of the
sampling procedure. We did not find sex differences in
basal cortisol levels, which is in agreement with Reimers
et al. 1990 [13] who did not find any effect of gender on
cortisol concentrations in healthy dogs. On the other
hand, the concentration of the precursor of cortisol  cho-
lesterol  was higher in female dogs than males (6.2 vs 5.2
mmol/L), in agreement with Barrie et al 1993 [21].
This study showed that gender affected the cortisol
response of the animals when stimulated with ACTH or
inhibited with Dexamethasone.
Dexamethasone inhibition of cortisol secretion differed
according to sex, as inhibition lasted longer in females
than in males. We have not found any reports on different
response by gender in Dexamethasone-treated dogs. In
humans, the glucocorticoid sensitivity measured by a Dex-
amethasone suppression test and the combined Dexame-
thasone suppression/CRH stimulation (Dex-CRH) test
used to evaluate the degree of HPA-axis dysregulation in
patients with unipolar depression have been shown to be
affected by sex [22]. Moreover, in rats, estrogen treatment
reduced type I receptors in the anterior pituitary by
5060%; this down-regulatory effect was seen only in
female rats and no change was found for males suggesting
that the regulation was steroid independent [23]. Whether
the prolonged Dexamethasone inhibition on cortisol
secretion in dogs is due to differential pituitary/hypotha-
lamus sensitivity to glucocorticoids remains to be eluci-
dated.
ACTH response  in terms of cortisol secretion  was also
affected by gender as females presented higher cortisol
concentrations than males. This is in agreement with
reports in other species (rat [24,25]; sheep in vitro [26];
sheep in vivo [27]). Since the treatment was with exoge-
nous ACTH, we can suggest that the peripheral response
of the adrenal glands to ACTH has a different regulation
among sexes. We have found no reports on different sen-
sitivity of the adrenal gland to ACTH in dogs. On the other
hand, we have previously shown the existence of estrogen
receptor alpha (ERα) in the sheep adrenal gland and
found a varying sensitivity to oestrogens as the ER levels
differed according to sex and gonadal status, with the ewes
having higher ER levels than rams [27]. These findings
indicate that oestrogens most likely affect steroidogenesis
directly at the adrenal cortex and suggest that oestrogens
are partly responsible for the sex differences in cortisol
secretion in sheep. Possible mechanisms by which oestro-
Cortisol concentrations in female and male healthy Cocker  Spaniel dogs after Dexamethasone (A), ACTH (B) and Saline  solution (C) treatments Figure 3
Cortisol concentrations in female and male healthy 
Cocker Spaniel dogs after Dexamethasone (A), 
ACTH (B) and Saline solution (C) treatments. 
Observe that the scale in B panel is different from A and C 
panels. Open dots: females. Solid line: males.
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gens might affect adrenal steroidogenesis have been sug-
gested: influence on adrenocortical sensitivity to ACTH
[28,29]; stimulatory effect on the induction of enzymes in
the synthesis of glucocorticoids [30]; and/or increase in
availability of steroid precursor (cholesterol) by affecting
the steroidogenic acute regulatory (StAR) protein [31,32].
In this study the plasma concentrations of the steroid pre-
cursor  cholesterol  in female dogs was higher than in
males (Figure 2A), as previously shown in the Beagle
breed [33]. This finding suggests that the higher cortisol
levels found in females after ACTH test is due -at least par-
tially- to a higher availability of its precursor: cholesterol.
We have not found any studies on the mechanisms by
which oestrogens participate in the regulation of adrenal
cortex functions, e.g. cortisol secretion, in dogs.
Conclusion
In summary, we have demonstrated that the cortisol
response to ACTH and Dexamethasone treatment in dogs
differs according to sex.
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